Benedikt Schrage, ESC 2019 – Implantable Devices and Heart Failure
We spoke to Dr Benedikt Schrage (Karolinska Institute, Stockholm, Sweden) for the key findings from his prospective study examining the association between the use of implantable cardioverter defibrillators and mortality in patients with heart failure. He also discusses how physicians might incorporate these findings into routine practice.
Speaker’s Disclosures: Benedikt Schrage has received funding from the German Research Foundation and received speaker’s fees from AstraZeneca.
Questions:
1. What were the key findings from your prospective study that examined the association between implantable cardioverter-defibrillator use and mortality in patients with heart failure? (0:05)
2. How should physicians incorporate these observations into routine practice when considering implantable devices for their patients with heart failure? (1:20)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Society of Cardiology (ESC) Congress 2019 in Paris, France, September 2019.
